Trends in HPV-dependent and HPV-independent vulvar cancers: The changing face of vulvar squamous cell carcinoma
Gynecologic Oncology Feb 18, 2020
Eva LJ, et al. - Researchers sought to present the first evidence of the incidence of vulvar squamous cell carcinoma (VSCC) by etiology over a 27 year period. They reviewed retrospective case-note and pathology slides of 390 consecutive VSCC, who underwent treatment at a Centralized Cancer Centre covering half New Zealand's population, 1990–2016. No significant change in age-standardized incidence of all VSCC was identified, however, there was a significant increase in age-standardized incidence of HPV-dependent VSCC, from 0.55/100,000 in 1991–2000 to 0.83/100,000 in 2001–2016, with a significant decrease in the incidence of HPV-independent VSCC, from 0.76/100,000 to 0.54/100,000. Older women (≥ 50 years) exhibited a significant increase in HPV-dependent VSCC incidence, from 0.75/100,000 to 1.43/100,000. They identified approximately equal proportions of HPV-dependent and independent VSCC. Five-year survival for HPV-dependent VSCC and HPV-independent VSCC is 93% and 68%, respectively. Based on this study, they recommend separating HPV-dependent and independent VSCC in registries and studies.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries